Skip to main content
Clinical Trials/JPRN-jRCT1030220680
JPRN-jRCT1030220680
Recruiting
未知

Patient preferences of treatment for the patients suffering from muscle-invasive urothelial carcinoma of bladder following radical cystectomy in Japan (SNUGGLE) - SNUGGLE

akano Tomoyoshi0 sites115 target enrollmentMarch 3, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Muscle-invasie urothelial carcinoma
Sponsor
akano Tomoyoshi
Enrollment
115
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 3, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
akano Tomoyoshi

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients residing in Japan and able to speak/read Japanese for the interview/survey
  • 2\. Patients aged 18 years or more at the time of consent
  • 3\. Patients with a pathological diagnosis of MIBC (either of the following):
  • \- ypT2\-ypT4a or ypN\+ MIBC, with prior neoadjuvant cisplatin chemotherapy and who underwent radical cystectomy
  • \- pT3\-pT4a or pN\+ MIBC, without prior neoadjuvant cisplatin chemotherapy and who underwent radical cystectomy
  • 4\. Patients who have not received any treatment related to MIBC after radical cystectomy
  • 5\. Patients who are able and willing to provide written informed consent to participate in this study

Exclusion Criteria

  • 1\.Patient is determined by the physician as being unsuitable for the study
  • 2\.Patient has a confirmed diagnosis of other primary cancer(s) at the time of obtaining consent
  • 3\.Patient is currently participating in a MIBC clinical trial

Outcomes

Primary Outcomes

Not specified

Similar Trials